Press Releases about Astrazeneca Plc ADR
Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis
January 24, 2022
From AstraZeneca
Via Business Wire
Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019
January 14, 2022
Topics
Death
Exposures
Death
From AstraZeneca
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|